Entrar Registro gratuito

QSAM Biosciences Margem bruta

Qual é o Margem bruta de QSAM Biosciences?

O Margem bruta de QSAM Biosciences, Inc. é 116.73%

Qual é a definição de Margem bruta?



A margem bruta é a diferença entre a receita e o custo dos produtos vendidos, dividida por receita e expressa em porcentagem.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margem bruta de empresas na Setor Health Care em OTC em comparação com QSAM Biosciences

O que QSAM Biosciences faz?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Empresas com margem bruta semelhantes a QSAM Biosciences